Product
Anti-SARS-CoV-2 mAb
1 clinical trial
2 indications
Indication
COVID-19Indication
Healthcare-associated infectionClinical trial
Canadian Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of Nosocomial Acquired COVID-19 PatientsStatus: Terminated, Estimated PCD: 2022-01-31